Skip to main content
. 2017 May 25;10(7):545–552. doi: 10.1177/1756283X17709974

Figure 1.

Figure 1.

MMX® technology release throughout the gastrointestinal tract. The gastro-resistant coating (1–2) avoids the release of the drug until the tablet is exposed to a pH ⩾ 7, normally reached in the terminal ileum (3). After reaching this site, the activity of the tablet core results in a homogeneous and prolonged exposure of the whole colonic mucosa to the embedded drug (4).